Literature DB >> 30069313

Five-year survival analysis and prognostic factors in patients operated on for non-small cell lung cancer with N2 disease.

Mariusz Łochowski1, Barbara Łochowska2, Marek Rębowski1, Daniel Brzeziński1, Bartosz Cieślik-Wolski1, Józef Kozak1.   

Abstract

BACKGROUND: The aim of the study is to analyse 5-year survival and prognostic factors in patients operated due to lung cancer with postoperatively confirmed metastases to N2 group nodes.
METHODS: In the years 2007-2015, 1,148 patients with lung cancer were treated surgically. A postoperative histopathological study confirmed N2 feature in 150 patients. One hundred and ten patients, in whom a 5-year survival analysis was possible to perform, were included in such analysis. The patients underwent the following procedures: pneumonectomy, 31 patients; lobectomy, 61; bilobectomy, 10; and wedge resection, 8. All patients were subjected to supplementary treatment after the surgery.
RESULTS: Five-year survival was achieved in 23 patients (21%). The patients' survival did not depend on the type of surgery, type of tumour, its location or presence of metastases in N1 nodes (P=0.82, P=0.51, P=0.36 and P=0.23, respectively). A statistically significant correlation was observed (P=0.01) between the 5-year survival of a patient and the occurrence of metastases only in one group of lymph nodes of the N2 feature (22 patients, 20%). Involvement of three or more mediastinal nodal groups resulted in survival shorter than 5-year.
CONCLUSIONS: (I) In patients with the N2 feature, the type of performed surgery, type of tumour and the occurrence of metastases in the lymph nodes of the lung hilum do not affect 5-year survival; (II) involvement of only one nodal group allows to achieve 5-year survival in 20% of patients; (III) involvement of three and more nodal groups with the N2 feature results in decreased 5-year survival.

Entities:  

Keywords:  N2 disease; Non-small cell lung cancer (NSCLC); prognostic factors; surgery; survival

Year:  2018        PMID: 30069313      PMCID: PMC6051815          DOI: 10.21037/jtd.2018.05.173

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  22 in total

1.  Significant prognostic factors for completely resected pN2 non-small cell lung cancer without neoadjuvant therapy.

Authors:  Hirofumi Uehara; Masayuki Nakao; Mingyon Mun; Ken Nakagawa; Makoto Nishio; Yuichi Ishikawa; Sakae Okumura
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-02-16       Impact factor: 1.520

2.  A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.

Authors:  Hisashi Saji; Masahiro Tsuboi; Yoshihisa Shimada; Yasufumi Kato; Koichi Yoshida; Masaharu Nomura; Jun Matsubayashi; Toshitaka Nagao; Masatoshi Kakihana; Jitsuo Usuda; Naohiro Kajiwara; Tatsuo Ohira; Norihiko Ikeda
Journal:  Chest       Date:  2013-06       Impact factor: 9.410

3.  Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer.

Authors:  Nenad Ilic; Ante Petricevic; Dragan Arar; Slavica Kotarac; Josip Banovic; Nives Frleta Ilic; Andro Tripkovic; Leo Grandic
Journal:  J Thorac Oncol       Date:  2007-11       Impact factor: 15.609

4.  Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.

Authors:  Masayoshi Inoue; Noriyoshi Sawabata; Shin-ichi Takeda; Mitsunori Ohta; Yuko Ohno; Hajime Maeda
Journal:  J Thorac Cardiovasc Surg       Date:  2004-04       Impact factor: 5.209

5.  Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.

Authors:  Steven M Keller; Mark G Vangel; Henry Wagner; Joan H Schiller; Arnold Herskovic; Ritsuko Komaki; Randolph S Marks; Michael C Perry; Robert B Livingston; David H Johnson
Journal:  J Thorac Cardiovasc Surg       Date:  2004-07       Impact factor: 5.209

6.  Candidates for Intensive Local Treatment in cIIIA-N2 Non-Small Cell Lung Cancer: Deciphering the Heterogeneity.

Authors:  Hidehito Horinouchi; Yasushi Goto; Shintaro Kanda; Yutaka Fujiwara; Hiroshi Nokihara; Noboru Yamamoto; Minako Sumi; Tomohide Tamura; Yuichiro Ohe
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-09-26       Impact factor: 7.038

7.  Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.

Authors:  Giuseppe Marulli; Enrico Verderi; Andrea Zuin; Marco Schiavon; Lucia Battistella; Egle Perissinotto; Paola Romanello; Adolfo Gino Favaretto; Giulia Pasello; Federico Rea
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-05-13

Review 8.  Staging lymph node metastases from lung cancer in the mediastinum.

Authors:  Mario D Terán; Malcolm V Brock
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

9.  Lymph node metastasis according to primary tumor location in T1 and T2 stage non-small cell lung cancer patients.

Authors:  Jian Xiong; Rui Wang; Yihua Sun; Haiquan Chen
Journal:  Thorac Cancer       Date:  2016-01-04       Impact factor: 3.500

10.  Clinical analysis of sixty-four patients with T1aN2M0 stage non-small cell lung cancer who had undergone resection.

Authors:  Jian Xiong; Rui Wang; Yihua Sun; Haiquan Chen
Journal:  Thorac Cancer       Date:  2015-10-06       Impact factor: 3.500

View more
  4 in total

1.  Risk analyses of N2 lymph-node metastases in patients with T1 non-small cell lung cancer: a multi-center real-world observational study in China.

Authors:  Bing Chen; Wenjie Xia; Zhongqiu Wang; Heng Zhao; Xiaofei Li; Lunxu Liu; Yang Liu; Jian Hu; Xiangning Fu; Yin Li; Yijun Xu; Deruo Liu; Haiying Yang; Lin Xu; Feng Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-19       Impact factor: 4.553

2.  Nodal Involvement Pattern in Clinical Stage IA Non-Small Cell Lung Cancer According to Tumor Location.

Authors:  Shushi Meng; Ganwei Liu; Shaodong Wang; Fan Yang; Jun Wang
Journal:  Cancer Manag Res       Date:  2020-08-26       Impact factor: 3.989

3.  Tumor size as a predictor for prognosis of patients with surgical IIIA-N2 non-small cell lung cancer after surgery.

Authors:  Kunpeng Zhang; Jiahao Cai; Chunlai Lu; Qiaoliang Zhu; Cheng Zhan; Yaxing Shen; Jie Gu; Di Ge
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

4.  Up-Regulation of FSTL3, Regulated by lncRNA DSCAM-AS1/miR-122-5p Axis, Promotes Proliferation and Migration of Non-Small Cell Lung Cancer Cells.

Authors:  Liang Gao; Xiaochen Chen; Yongxiang Wang; Jianbin Zhang
Journal:  Onco Targets Ther       Date:  2020-04-01       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.